QR Code

A comparison of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs

Background: To eliminate hepatitis C (HCV) infection as a public health concern by 2030, there is a need to develop comprehensive programs among key populations such as people who use drugs (PWUD). Two highly effective regimens are available for initial therapy: glecaprevir/pibrentasvir (G/P) given...

Full description

Saved in:
Main Authors: Shana Yi, David Truong, Brian Conway
Format: Artigo
Language:Inglês
Published: Elsevier 2024-09-01
Series:Journal of Virus Eradication
Subjects:
DAA
Hepatitis C
Glecaprevir/pibrentasvir
Sofosbuvir/velpatasvir
People who inject drugs
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664024000256
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items